Christophe Bonny

citizen of Chevroux, Avenches

Commercial register

Managing director · avec 200 parts de CHF 100 · sole signature · Avenches

since Aug 13, 2014

Member of the board of directors · joint signature by two · Sion

since Aug 14, 2013

Owner · sole signature · Le Chenit

since Oct 26, 2005

Member of the board of directors · joint signature by two · Chevroux

until Nov 20, 2024

Vice-chair of the board of directors · sole signature · Le Chenit

until Sep 9, 2021

Vice-chair of the board of directors · sole signature

until May 11, 2018

Member of the board of directors · joint signature by two

until Jan 23, 2012

Director · joint signature by two · Lausanne

until Sep 14, 2010

joint signature by two

until Sep 30, 2008

joint signature by two

until Feb 9, 2006

Member of the board of directors · joint signature by two

until Dec 3, 2003

Trademarks, designs and patents

NEUARTIGE JNK-HEMMERMOLEKÜLE

European patent · EP2993180 · Inventor

Deleted
Verwendung von zelldurchlässigen Peptidhemmern des JNK-Signaltransduktionsweges zur Behandlung verschiedener Krebs-Erkrankungen

European patent · EP2650008 · Inventor

Deleted
VERWENDUNG VON ZELLDURCHLÄSSIGEN PEPTIDHEMMERN DES JNK-SIGNALTRANSDUKTIONSWEGES ZUR BEHANDLUNG VERSCHIEDENER KRANKHEITEN

European patent · EP2985031 · Inventor

Deleted
Verwendung von zellpermeablen Peptid-Inhibitoren des JNK-Signal-Transduktionspfads zur Behandlung verschiedener kardiovaskulären Erkrankungen

European patent · EP2491942 · Inventor

Deleted
Verwendung von Zellpermeablen Peptid-Inhibitoren des JNK-Signal-Transduktionspfads zur Behandlung verschiedener Erkrankungen

European patent · EP2489361 · Inventor

Deleted
Verwendung von zelldurchlässigen Peptidhemmern des JNK-Signaltransduktionsweges zur Behandlung verschiedener Autoimmunerkrankungen

European patent · EP2650007 · Inventor

Deleted
Zelldurchlässige Peptidhemmer des JNK-Signaltransduktionsweges

European patent · EP2418217 · Inventor

Deleted
Zell-durchlässige Peptidinhibitoren des JNK-Signaltransduktionsweges

European patent · EP1776958 · Inventor

Deleted
Zelldurchlässige Peptidhemmer des JNK-Signaltransduktionsweges

European patent · EP2060265 · Inventor

Deleted
Zelldurchlässige Peptidhemmer des JNK-Signaltransduktionsweges

European patent · EP1911458 · Inventor

Deleted
Zelldurchlässige Peptidhemmer des JNK-Signaltransduktionsweges

European patent · EP1895005 · Inventor

Deleted
Zelldurchlässige Peptidhemmer des JNK-Signaltransduktionsweges

European patent · EP1811033 · Inventor

Deleted
Zelldurchlässige Peptidhemmer des JNK-Signaltransduktionsweges

European patent · EP1905830 · Inventor

Deleted
Transkriptionsfaktor Islet-Brain 1 (IB1)

European patent · EP1889913 · Inventor

Deleted